BG
ICPT
Bellevue Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,000
| Closed | -$185K | – | 225 |
|
|
2021
Q1 | $185K | Hold |
8,000
| – | – | ﹤0.01% | 215 |
|
|
2020
Q4 | $198K | Sell |
8,000
-696,976
| -99% | -$17.3M | ﹤0.01% | 220 |
|
|
2020
Q3 | $29.2M | Hold |
704,976
| – | – | 0.4% | 68 |
|
|
2020
Q2 | $33.8M | Sell |
704,976
-4,000
| -0.6% | -$192K | 0.48% | 54 |
|
|
2020
Q1 | $44.6M | Sell |
708,976
-6,200
| -0.9% | -$390K | 0.87% | 33 |
|
|
2019
Q4 | $88.6M | Buy |
715,176
+13,000
| +2% | +$1.61M | 1.41% | 20 |
|
|
2019
Q3 | $46.6M | Sell |
702,176
-9,627
| -1% | -$639K | 0.87% | 34 |
|
|
2019
Q2 | $56.6M | Buy |
711,803
+694,576
| +4,032% | +$55.3M | 0.97% | 31 |
|
|
2019
Q1 | $1.93M | Sell |
17,227
-5,921
| -26% | -$662K | 0.11% | 110 |
|
|
2018
Q4 | $2.33M | Sell |
23,148
-1,000
| -4% | -$101K | 0.15% | 94 |
|
|
2018
Q3 | $3.05M | Sell |
24,148
-500
| -2% | -$63.2K | 0.19% | 94 |
|
|
2018
Q2 | $2.07M | Sell |
24,648
-7,252
| -23% | -$608K | 0.18% | 86 |
|
|
2018
Q1 | $1.96M | Buy |
31,900
+12,500
| +64% | +$769K | 0.19% | 80 |
|
|
2017
Q4 | $1.13M | Buy |
19,400
+10,900
| +128% | +$637K | 0.12% | 106 |
|
|
2017
Q3 | $493K | Hold |
8,500
| – | – | 0.05% | 124 |
|
|
2017
Q2 | $1.03M | Hold |
8,500
| – | – | 0.12% | 101 |
|
|
2017
Q1 | $961K | Hold |
8,500
| – | – | 0.13% | 104 |
|
|
2016
Q4 | $924K | Sell |
8,500
-5,000
| -37% | -$544K | 0.19% | 88 |
|
|
2016
Q3 | $2.22M | Hold |
13,500
| – | – | 0.4% | 71 |
|
|
2016
Q2 | $1.93M | Hold |
13,500
| – | – | 0.36% | 74 |
|
|
2016
Q1 | $1.73M | Buy |
+13,500
| New | +$1.73M | 0.31% | 82 |
|